Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Kidney and Pancreas Transplant Market By Organ Type (Kidney, Pancreas), End-User (Hospitals, Transplant Centers, Others), Sources (Living Donors, Deceased Donors) – Industry Trends and Forecast to 2029
Market Analysis and Size
The industry is also benefiting from an increase in the number of organ donors around the world and an increase in the number of transplant surgeries. Furthermore, the rapid development of the medical sector, well-developed healthcare sectors, and more significant healthcare expenditure are all essential aspects driving the Kidney and Pancreas transplant market forward.
Data Bridge Market Research analyses that the kidney and pancreas transplant market which was USD 12.95 billion in 2021, would rocket up to USD 30.94 billion by 2029, and is expected to undergo a CAGR of 11.50% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
When a person develops renal failure due to type 1 diabetes, a kidney and pancreas transplant is performed. In this case, either both organs are from the same patient or one is from a living patient and the other is from a deceased patient. The expansion of this industry is fueled by an increase in the number of organ donors worldwide.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Organ Type (Kidney, Pancreas), End-User (Hospitals, Transplant Centers, Others), Sources (Living Donors, Deceased Donors) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
AbbVie Inc. (U.S.), Arthrex, Inc. (U.S), Medtronic (U.S), Novartis AG (U.S), Stryker (U.S), Teva Pharmaceutical Industries Ltd. (Israel), Veloxis Pharmaceuticals, Inc. (U.S.), Zimmer Biomet (U.S), Dr. Franz Köhler Chemie GmbH(Germany), Organogenesis Inc. (U.S) |
|
Market Opportunities |
|
Kidney and Pancreas Transplant Market Dynamics
Drivers
Number of chronic diseases and organ failure is on the rise
The kidney, in particular, is one of the significant causes driving the development and demand for Kidney and Pancreas transplants. Furthermore, the increased incidence of renal disorders as a result of high alcohol use and a poor diet is contributing to the global market's rise.
Number of organ donors is rapidly increasing
The expanding number of transplant surgeries performed around the world is also boosting the market's growth. Furthermore, the rapid development of the medical sector, well-developed healthcare sectors, and more significant healthcare expenditure are all crucial aspects driving the kidney and pancreas transplant market forward.
Opportunities
The increasing public awareness concerning organ donation and transplantation, growing public-private funding for target research activities and improving healthcare infrastructure offer substantial growth opportunities.
Restraints/Challenges
Transplantation of the kidneys and pancreas carries many risks. The high cost of transplantation is limiting the market. However, the high cost of transplantation, insufficient donor numbers, and increased incidence of organ failure would limit the growth of the Kidney and Pancreas transplant market. In contrast, the significant risks associated with kidney and pancreatic transplantation may threaten the market's growth.
This kidney and pancreas transplant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kidney and pancreas transplant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Kidney and Pancreas Transplant Market
The market suffered a setback as a result of the introduction of tight lockdown measures and travel restrictions during COVID-19. Elective procedures have been delayed due to COVID-19-related regulation, which had a negative impact on the Kidney and Pancreas transplant market. Operating rooms were temporarily converted to respiratory support units in areas with a high illness burden. To handle sick patients affected by COVID19, post-operative recovery rooms and intermediate care units were used as care units outside of conventional critical care.
Recent Development
- The NYU Langone Transplant Institute announced a new pancreatic transplantation program in February 2019, expanding access to patients with diabetes and other illnesses. The major goal is to grow their business and become one of its most extensive transplant facilities.
Global Kidney and Pancreas Transplant Market Scope
The kidney and pancreas transplant market is segmented on the basis of type, sources, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Organ Type
- Kidney
- Pancreas
End-User
- Hospitals
- Transplant Centers
- Others
Sources
- Living Donors
- Deceased Donors
Kidney and Pancreas Transplant Market Regional Analysis/Insights
The kidney and pancreas transplant market is analyzed and market size insights and trends are provided by country, type, price range, application and end-user as referenced above.
The countries covered in the kidney and pancreas transplant market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global market for organ transplantation. Rising incidence of organ failure, growing advances in the medical sector, well-developed health services, and higher health spending are subsidizing the American market's growth.
The Asia-Pacific region is the fastest-growing region during the forecast period of 2022 to 2029. Emerging markets and a growing population of chronic diseases are key influences for the Asia-Pacific industry.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The kidney and pancreas transplant market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for kidney and pancreas transplant market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the kidney and pancreas transplant market. The data is available for historic period 2010-2020.
Competitive Landscape and Kidney and Pancreas Transplant Market Share Analysis
The kidney and pancreas transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to kidney and pancreas transplant market.
Some of the major players operating in the kidney and pancreas transplant market are:
- AbbVie Inc. (U.S)
- Arthrex, Inc. (U.S)
- Medtronic (U.S)
- Novartis AG (U.S)
- Stryker (U.S)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Veloxis Pharmaceuticals, Inc. (U.S)
- Zimmer Biomet (U.S)
- Dr. Franz Köhler Chemie GmbH (Germany)
- Organogenesis Inc. (U.S)
SKU-
